FDG PET/CT in the Management of Nasopharyngeal Carcinoma
Authors:
- 1 August 2014
- journal article
- review article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 203 (2) , W146-W157
Abstract
FDG PET/CT has a growing role in the diagnosis and management of nasopharyngeal carcinoma (NPC). FDG PET has greater efficacy for N and M staging than other modalities, which enables the treating oncologists to select the appropriate mode of treatment. FDG PET/CT helps in radiation therapy planning, provides valuable prognostic information, and is useful in the assessment of therapy response and in follow-up to detect recurrences. FDG PET/CT is a valuable imaging test in the management of NPC.Keywords
This publication has 45 references indexed in Scilit:
- FDG PET/CT in the Management of Primary Pleural Tumors and Pleural MetastasesAmerican Journal of Roentgenology, 2013
- The Role of PET/CT in the Management of Cervical CancerAmerican Journal of Roentgenology, 2013
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- PET/CT of Cancer Patients: Part 1, Pancreatic NeoplasmsAmerican Journal of Roentgenology, 2012
- Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapyAnnals of Nuclear Medicine, 2012
- Parotid Gland Tumors: Preliminary Data for the Value of FDG PET/CT Diagnostic ParametersAmerican Journal of Roentgenology, 2012
- Use of 18F-FDG PET/CT as a Predictive Biomarker of Outcome in Patients With Head-and-Neck Non–Squamous Cell CarcinomaAmerican Journal of Roentgenology, 2011
- FDG PET/CT in Patients With HIVAmerican Journal of Roentgenology, 2011
- Squamous Cell Carcinoma of the Palatine Tonsils: FDG Standardized Uptake Value Ratio as a Biomarker to Differentiate Tonsillar Carcinoma from Physiologic UptakeRadiology, 2010
- 18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesotheliomaJournal of Medical Imaging and Radiation Oncology, 2009